134 related articles for article (PubMed ID: 18685447)
1. Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
Illoh OC; Illoh K
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):605-7. PubMed ID: 18685447
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation.
Brunner F; Tomandl B; Schröter A; Mellinghoff C; Haldenwanger A; Hildebrandt H; Kastrup A
Eur J Neurol; 2011 Dec; 18(12):1407-11. PubMed ID: 21672089
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
[TBL] [Abstract][Full Text] [Related]
4. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
Lee VH; Conners JJ; Cutting S; Song SY; Bernstein RA; Prabhakaran S
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2139-2144. PubMed ID: 25081309
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic complications of thrombolytic therapy.
Vujković Z; Racić D; Miljković S; Dajić V
Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
8. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
9. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
Wang CT; Lin FC; Khor GT; Chen CH; Huang P
Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385
[TBL] [Abstract][Full Text] [Related]
10. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: the SEDAN score.
Brüning T; Al-Khaled M
CNS Neurosci Ther; 2015 Mar; 21(3):296-7. PubMed ID: 25622691
[No Abstract] [Full Text] [Related]
11. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy for acute stroke in a teenager.
Muñiz AE
Pediatr Emerg Care; 2012 Feb; 28(2):170-3. PubMed ID: 22307187
[TBL] [Abstract][Full Text] [Related]
13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.
Lyden PD
J Stroke Cerebrovasc Dis; 2013 May; 22(4):532-8. PubMed ID: 23453556
[TBL] [Abstract][Full Text] [Related]
15. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
[No Abstract] [Full Text] [Related]
16. Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions.
Bussard ME
Crit Care Nurse; 2002 Jun; 22(3):57-63. PubMed ID: 12092294
[TBL] [Abstract][Full Text] [Related]
17. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
18. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
[No Abstract] [Full Text] [Related]
19. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolytic therapy for acute ischemic stroke.
Wechsler LR
N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
